Akt and PTEN: New diagnostic markers of non-small cell lung cancer?

被引:19
|
作者
David, O [1 ]
机构
[1] Tulane Univ, Hlth Sci Ctr, New Orleans, LA 70112 USA
关键词
Akt; PTEN; cell survival; immunohistochemistry; lung cancer;
D O I
10.1111/j.1582-4934.2001.tb00178.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We are particularly interested in testing the principles of cell proliferation and apoptosis in the microenvironment of human lung cancers with respect to the cell survival protein Akt (1) and PTEN (2). Akt is a cytosolic protein which promotes cell survival by phosphorylative inactivation of targets in apoptotic pathways. Akt has been found to play a role in the survival of experimental cancer cell lines in breast, prostate, ovary, lung and brain tissue. PTEN is a tumor suppressor gene whose protein product is expressed in inverse proportion to phosphorylated Akt in endometrial and breast cancer cell lines. No studies of the diagnostic significance of Akt and PTEN in human lung cancers have been reported.
引用
收藏
页码:430 / 433
页数:4
相关论文
共 50 条
  • [41] Standardization of Molecular Diagnostic Testing for Non-small Cell Lung Cancer
    Karimnezhad, A.
    Lo, B.
    Campbell, P.
    Stewart, D.
    Perkins, T.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 965 - 966
  • [42] Diagnostic and Therapeutic Implications of microRNAs in Non-Small Cell Lung Cancer
    Ahn, Young-Ho
    Ko, Yoon Ho
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (22) : 1 - 17
  • [43] Clinicopathological significance of PTEN and PI3K/AKT signal transduction pathway in non-small cell lung cancer
    Yun, Fen
    Jia, Yongfeng
    Li, Xiuxia
    Yuan, Li
    Sun, Qinnuan
    Yu, Huiling
    Shi, Lin
    Yuan, Hongwei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2013, 6 (10): : 2112 - 2120
  • [44] PTEN and PI3K/AKT in non-small-cell lung cancer
    Perez-Ramirez, Cristina
    Canadas-Garre, Marisa
    Angel Molina, Miguel
    Jose Faus-Dader, Maria
    Angel Calleja-Hernandez, Miguel
    PHARMACOGENOMICS, 2015, 16 (16) : 1843 - 1862
  • [45] GCC2 as a New Early Diagnostic Biomarker for Non-Small Cell Lung Cancer
    Jeong, Hyesun
    Choi, Byeong Hyeon
    Park, JinA
    Jung, Jik-Han
    Shin, Hyunku
    Kang, Ka-Won
    Quan, Yu Hua
    Yu, Jewon
    Park, Ji-Ho
    Park, Yong
    Choi, Yeonho
    Kim, Hyun Koo
    Hong, Sunghoi
    CANCERS, 2021, 13 (21)
  • [46] ANALYSIS OF PTEN MUTATION STATUS IN CHINESE PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Su, Jian
    An, She-Juan
    Huang, Ying
    Chen, Shi-Liang
    Guo, Wei-Bang
    Chen, Zhi-Hong
    Tang, Hong-Yan
    Zhi, Xie
    Chen, Jian-Guang
    Zhang, Xu-Chao
    Wu, Yi-Long
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S960 - S961
  • [47] Molecular Characteristics of Patients with PTEN Mutations in Chinese Non-Small Cell Lung Cancer
    Zheng, X.
    Xu, C.
    Wang, W.
    Zhuang, W.
    Song, Z.
    Zhu, Y.
    Chen, R.
    Guan, Y.
    Yi, X.
    Chen, Y.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2104 - S2105
  • [48] Non-small cell lung cancer
    Nestle, U.
    Hoffmann, H.
    Reck, M.
    Bruns, C.
    ONKOLOGIE, 2022, 28 (12): : 1034 - 1037
  • [49] Non-small cell lung cancer
    Hill, Andrew
    Fisher, Patricia
    Yeomanson, Dan
    BRITISH MEDICAL JOURNAL, 2012, 345
  • [50] Non-small cell lung cancer
    Besse, B.
    Vignot, S.
    ONCOLOGIE, 2013, 15 (7-8) : 371 - 376